Latest filing published 08 Jan 2025 for GoodRx Holdings, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Karsten Voermann on record concern GoodRx Holdings, Inc., in the capacity of finance chief. Over a trading history stretching from 28 May 2021 to 8 January 2025, the count stands at 18 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 8 January 2025, reports an option exercise in GoodRx Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations